(2-Amino-5-bromophenyl)methanol, 98.0%, 1g

GC capillary column ROTI®Cap-1, 30 m, 0.32 mm, 0.10 µm, 1 Piece(s)

(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 25g

3,4-dihydroxyphenylacetic acid, 95.0%, 250g

2-Chloro-6-(N,N-dimethylamino)pyrazine, 98.0%, 100g

3,6,9,12,15-Pentaoxahexadecanoic acid, 95%, 1g

4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one, 95.0%, 5g

3-Hydroxy-2-nitrobenzaldehyde, 97%, 100mg

2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid, 1g

(3-Bromo-5-methylphenyl)methanol, 95.0%, 25g

Glycyl-L-glutamic acid, 95%, 1g

1-Phenyl-3-(trifluoromethyl)-1H-pyrazole, 95.0%, 100mg

4-bromo-2-ethynylaniline, 1g